References *Richard I
This transparency supports research quality and allows researchers to make informed decision on compound suitability for their use
This combination allows researchers to fine-tune protocols for optimal hormone stimulation
Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, Atzeni F, Behrens GM, Bijlsma WJ, Bhm P, Hyrich KL (2023) 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
Sulfonylureas : Like insulin, these can also raise the risk of hypoglycemia when used alongside semaglutide
R.DagostiniC.Abdel-LatifM